🇺🇸 FDA
Patent

US 8053448

Biphenyl compounds useful as muscarinic receptor antagonists

granted A61KA61K31/4545A61K45/06

Quick answer

US patent 8053448 (Biphenyl compounds useful as muscarinic receptor antagonists) held by Theravance, Inc. expires Mon Nov 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Nov 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K31/4545, A61K45/06, A61K9/124, A61K9/1623